Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63:747–62. https://doi.org/10.1016/j.jacc.2013.09.070.

Article  PubMed  Google Scholar 

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-156. https://doi.org/10.1093/gerona/56.3.m146.

Article  CAS  PubMed  Google Scholar 

Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722–7. https://doi.org/10.1093/gerona/62.7.722.

Article  PubMed  Google Scholar 

Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet Lond Engl. 2019;394:1365–75. https://doi.org/10.1016/S0140-6736(19)31786-6.

Article  Google Scholar 

Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet Lond Engl. 2019;394:1376–86. https://doi.org/10.1016/S0140-6736(19)31785-4.

Article  Google Scholar 

Nan J, Duan Y, Wu S, Liao L, Li X, Zhao Y, et al. Perspectives of older adults, caregivers, healthcare providers on frailty screening in primary care: a systematic review and qualitative meta-synthesis. BMC Geriatr. 2022;22:482. https://doi.org/10.1186/s12877-022-03173-6.

Article  PubMed  PubMed Central  Google Scholar 

Butt JH, Dewan P, Merkely B, Belohlávek J, Drożdż J, Kitakaze M, et al. Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial. Ann Intern Med. 2022;175:820–30. https://doi.org/10.7326/M21-4776.

Article  PubMed  Google Scholar 

James K, Jamil Y, Kumar M, Kwak MJ, Nanna MG, Qazi S, et al. Frailty and cardiovascular health. J Am Heart Assoc. 2024;13: e031736. https://doi.org/10.1161/JAHA.123.031736.

Article  PubMed  Google Scholar 

Damluji AA, Chung S-E, Xue Q-L, Hasan RK, Moscucci M, Forman DE, et al. Frailty and cardiovascular outcomes in the National Health and Aging Trends Study. Eur Heart J. 2021;42:3856–65. https://doi.org/10.1093/eurheartj/ehab468.

Article  PubMed  PubMed Central  Google Scholar 

Aïdoud A, Gana W, Poitau F, Debacq C, Leroy V, Nkodo J-A, et al. High prevalence of geriatric conditions among older adults with cardiovascular disease. J Am Heart Assoc. 2023;12: e026850. https://doi.org/10.1161/JAHA.122.026850.

Article  PubMed  PubMed Central  Google Scholar 

Marinus N, Vigorito C, Giallauria F, Haenen L, Jansegers T, Dendale P, et al. Frailty is highly prevalent in specific cardiovascular diseases and females, but significantly worsens prognosis in all affected patients: a systematic review. Ageing Res Rev. 2021;66: 101233. https://doi.org/10.1016/j.arr.2020.101233.

Article  PubMed  Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898. https://doi.org/10.1136/bmj.l4898.

Article  PubMed  Google Scholar 

Pandey A, Kitzman DW, Nelson MB, Pastva AM, Duncan P, Whellan DJ, et al. Frailty and effects of a multidomain physical rehabilitation intervention among older patients hospitalized for acute heart failure: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2023;8:167–76. https://doi.org/10.1001/jamacardio.2022.4903.

Article  PubMed  PubMed Central  Google Scholar 

Pandey A, Segar MW, Singh S, Reeves GR, O’Connor C, Piña I, et al. Frailty status modifies the efficacy of exercise training among patients with chronic heart failure and reduced ejection fraction: an analysis from the HF-ACTION trial. Circulation. 2022;146:80–90. https://doi.org/10.1161/CIRCULATIONAHA.122.059983.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanders NA, Supiano MA, Lewis EF, Liu J, Claggett B, Pfeffer MA, et al. The frailty syndrome and outcomes in the TOPCAT trial. Eur J Heart Fail. 2018;20:1570–7. https://doi.org/10.1002/ejhf.1308.

Article  CAS  PubMed  Google Scholar 

Wilkinson C, Wu J, Searle SD, Todd O, Hall M, Kunadian V, et al. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial. BMC Med. 2020;18:401. https://doi.org/10.1186/s12916-020-01870-w.

Article  PubMed  PubMed Central  Google Scholar 

Butt JH, Jhund PS, Belohlávek J, de Boer RA, Chiang C-E, Desai AS, et al. Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial. Circulation. 2022;146:1210–24. https://doi.org/10.1161/CIRCULATIONAHA.122.061754.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Simpson FR, Pajewski NM, Beavers KM, Kritchevsky S, McCaffery J, Nicklas BJ, et al. Does the impact of intensive lifestyle intervention on cardiovascular disease risk vary according to frailty as measured via deficit accumulation? J Gerontol A Biol Sci Med Sci. 2021;76:339–45. https://doi.org/10.1093/gerona/glaa153.

Article  CAS  PubMed  Google Scholar 

Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78. https://doi.org/10.1186/s12916-015-0328-1.

Article  PubMed  PubMed Central  Google Scholar 

White HD, Westerhout CM, Alexander KP, Roe MT, Winters KJ, Cyr DD, et al. Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Eur Heart J Acute Cardiovasc Care. 2016;5:231–42. https://doi.org/10.1177/2048872615581502.

Article  PubMed  Google Scholar 

Pulignano G, Del Sindaco D, Di Lenarda A, Tarantini L, Cioffi G, Gregori D, et al. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. J Cardiovasc Med Hagerstown Md. 2010;11:739–47. https://doi.org/10.2459/JCM.0b013e328339d981.

Article  Google Scholar 

Wang Z, Du X, Hua C, Li W, Zhang H, Liu X, et al. The effect of frailty on the efficacy and safety of intensive blood pressure control: a post hoc analysis of the SPRINT trial. Circulation. 2023;148:565–74. https://doi.org/10.1161/CIRCULATIONAHA.123.064003.

Article  CAS  PubMed  Google Scholar 

Dewan P, Jackson A, Jhund PS, Shen L, Ferreira JP, Petrie MC, et al. The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2020;22:2123–33. https://doi.org/10.1002/ejhf.1832.

Article  PubMed  Google Scholar 

Coats AJS, Butler J, Tsutsui H, Doehner W, Filippatos G, Ferreira JP, et al. Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved. J Cachexia Sarcopenia Muscle. 2024;15:412–24. https://doi.org/10.1002/jcsm.13393.

Article  PubMed  Google Scholar 

Leong DP, Bosch J, Bhatt DL, Avezum A, Yuan F, Yusuf S, et al. Impact of Frailty on the benefits of dual pathway inhibition for the secondary prevention of cardiovascular events in the COMPASS randomised trial. Can J Cardiol. 2024. https://doi.org/10.1016/j.cjca.2024.06.017.

Article  PubMed  Google Scholar 

Segar MW, Keshvani N, Singh S, Patel L, Parsa S, Betts T, et al. Frailty status modifies the efficacy of ICD therapy for primary prevention among patients with HF. JACC Heart Fail. 2024;12:757–67. https://doi.org/10.1016/j.jchf.2023.06.009.

Article  CAS  PubMed  Google Scholar 

Akashi S, Oguri M, Ikeno E, Manita M, Taura J, Watanabe S, et al. Outcomes and safety of very-low-dose edoxaban in frail patients with atrial fibrillation in the ELDERCARE-AF randomized clinical trial. JAMA Netw Open. 2022;5:e2228500. https://doi.org/10.1001/jamanetworkopen.2022.28500.

Article  PubMed  PubMed Central  Google Scholar 

Butt JH, Dewan P, Jhund PS, Anand IS, Atar D, Ge J, et al. Sacubitril/valsartan and frailty in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol. 2022;80:1130–43. https://doi.org/10.1016/j.jacc.2022.06.037.

Article  CAS  PubMed